<DOC>
	<DOCNO>NCT00644657</DOCNO>
	<brief_summary>This study explore effect clopidogrel coated-platelets patient give load dose diagnostic catheterization percutaneous coronary intervention . We hypothesis clopidogrel reduce percentage platelet coat therefore hypercoagulable .</brief_summary>
	<brief_title>The Effect Clopidogrel Coated-Platelets Patients Undergoing Cardiac Catheterization</brief_title>
	<detailed_description>Platelet activity determine light transmission aggregometry baseline , 300 mg dose clopidogrel catheterization and/or angioplasty procedure . The change percentage platelet coat platelet determine .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Chest Pain</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>Patients give clopidogrel load dose schedule catheterization percutaneous intervention Acute coronary syndrome Unable tolerate clopidogrel</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Platelets , platelet aggregation inhibitor</keyword>
</DOC>